Cannell & Spears’s Allergan Inc AGN Stock Holding History

Cannell & Spears’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-8,635	Closed	-$1.84M	–	150
2014 Q4	$1.84M	Hold	8,635	–	–	0.2%	49
2014 Q3	$1.54M	Buy	8,635 +320	+4%	+$53.1K	0.18%	51
2014 Q2	$1.41M	Buy	8,315 +2,015	+32%	+$314K	0.17%	50
2014 Q1	$782K	Hold	6,300	–	–	0.1%	58
2013 Q4	$700K	Hold	6,300	–	–	0.09%	60
2013 Q3	$570K	Sell	6,300 -1,100	-15%	-$98.7K	0.07%	67
2013 Q2	$623K	Buy	+7,400	New	+$768K	0.09%	60

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Cannell & Spears's AGN Position: Q1 2015 in Review

Cannell & Spears sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 8,635 shares — an estimated $1.84M sold.

Cannell & Spears first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $1.84M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Cannell & Spears reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Cannell & Spears sold 8,635 Allergan Inc shares in Q1 2015, an estimated $1.84M.
Cannell & Spears first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Cannell & Spears's Allergan Inc position peaked at $1.84M in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Cannell & Spears's 13F filing for Q1 2015, filed 14 May 2015.